Dr.Demet Demircioğlu
The term extrapyramidal system, coined by British neurologist Kinnier Wilson, refers to the basal ganglia and an array of brain stem nuclei (red nucleus, reticular formation etc.) to which they are connected.
Components of the extrapyramidal system include the red nuclei, vestibular nuclei, superior colliculus and reticular formation in the brain stem, all of which project via discrete pathways to influence spinal cord motor neurons. Cerebellar projections are also included since they influence not only these brainstem motor pathways, but also the motor cortex itself via the dentatothalamic projection.
Basal gangliaSubcortical nucleiCaudate,
putamen & globus pallidus: corpus straitum
Caudate & putamen : straitum
Globus pallidus & putamen : lentiform nuclei
Globus pallidus :pallidum
Perhaps the most important structures to retain an extrapyramidal definition are the basal ganglia, Subcortical cell stations for the extra pyramidal motor pathway
The neostriatum (caudate and putamen) receives widespread cortical afferents, including those from high order sensory association and motor areas, and projects mainly to the globus pallidus. The latter nucleus is the major outflow for the basal ganglia and, via the ventral anterior thalamus, exerts its major influence on premotor and hence the motor cortices.
This pattern of connections suggests that the basal ganglia are involved in complex aspects of motor control, including motor planning and the initiation of movement.
pyramidal system extrapyramidal system
function Skilful volitional
movements
Modulate volitional motor
movements
Finalizes an act Initiate an act
connection Direct linkage to
spinal cord
Multi neuronal and multi
synaptic via descending tracts
Cortico bulbar and
cortical spinal tract
reticulo-spinal, rubro-spinal,
olivo-spinal and vestibulo-spinal
tract.
Clinical features spasticity Rigidity( lead pipe/ cog wheel)
Reflexes brisk normal
Power diminished Usually not affected
Planters extensor flexor
Involuntary movements absent present
Phylogenetically, corpus striatum is primarilyresponsible for stereotyped motor activities tomaintain tone, posture, locomotion and automaticassociated movement.
Regulation of voluntary motor activity
Control of the muscle tone
Maintenance of emotional and associative movements
It is now clear that in many extrapyramidal disorders there are specific changes in neurotransmitter profile rather than discrete anatomical lesions
1. Disturbance in the control of voluntary motor activity resultingin involuntary movements which may be of two main types:
Rhythmic and regular as in parkinsonism Dysrhythmic and irregular as in chorea, athetosis and dystonia2. Disturbance in the normal muscle tone resulting in hypertonia
(rigidity)3. Disturbance in the maintenance of emotional and associated
movements resulting in bradykinesia (mask face, infrequentblinking and loss of swinging during walking)
Extrapyramidal disorders are classified
broadly on clinical grounds into:
1. The akinetic-rigid syndromes in which
poverty of movements predominates
2. The dyskinesisas in which there are a
variety of excessive involuntary
movements
Akinetic-rigid syndromes
Idiopathic Parkinson's disease
Drug-induced parkinsonism (e.g. phenothiazines)
MPTP-induced parkinsonism [methylphenyltetrahydropyridine]
Postencephalitic parkinsonism
Parkinsonism-plus
Childhood akinetic-rigid syndrome
Dyskinesias
Essential tremor
Chorea
Hemiballismus
Myoclonus
Tic or 'habit spasms'
Torsion dystonias
Paroxysmal dyskinesias
Rhythmical
Tremor
Irregular
Slow or sustained
(Athetosis / dystonia)Rapid
Controllable
(Tics)Uncontrollable
Distal
(Chorea)
Proximal
(Ballismus)
Multifocal
(Myoclonus)
Only Cogwheel
rigidity or rest
tremor
(Parkinsonism)
Cognitive, language,
upper motor neuron
or sensory sign
(Degenerative
disease with
parkinsonism)
Age- age of disease onset is very important tourettesyndrome, typically begins in the first decade, parkinsons disease usually occurs in late age
Past history –About infection (rheumatic fever), jaundice(wilsons disease) • Medical history & Toxin exposure
Drug history- of current, previous & recreational use should be taken details : parkinsonism & dystoniamay be produced by dopamine receptor blocking agent
Family history – should be taken and make a pedigree chart if necessary (huntington disease)
Associated neuropsychiatric features –Wilson disease, Huntington disease
Autonomic symptoms- dizziness, bladder complaints, impotence etc may be prominent & early in MSA, neurodegenerative disease
Alcohol responsiveness, essential tremor is characteristically response to alcohol
Specific distribution-• Chorea/ athetosis - mainly in the distal groups
• Hemiballismus- mainly proximally
• Parkinsons disease- mainly unilateral & asymmetric
• Blepherospasm- affect both eye
Specific action & relationship to voluntary movement-• task specific tremor (intention tremor) during pick up a
glass of water
• Task specific dystonia eg: Writers cramp, musiciancramp
Speed of movement-
Rhythm-Continuous – tremor Intermittent – astrexis
Relationship to sleep- Palatal myoclonus, segmental myoclonus, fasciculation & myokymia, persist during sleep , Dystoniadiminished on sleep
Supresibility- tics may be voluntary suppressed
Slow Intermediate Fast
Parkinsonism Chorea Myoclonus
Dystonia Tremor Tics
Athetosis
Aggravating or precipitating factor- stress and anxiety worsen all movement disorder • Myoclonus may be triggered by specific stimuli-
sudden loud noise or touch
• Carbohydrate heavy meal, fatigue may precipitateparoxysmal dystonia
Associated sensory symptom- RLS associated with pain or discomfort, tics may be associated with vague discomfort or abnormal sensation
Ameliorating factor- alcohol dramatically improved essential tremor and myoclonic dystonia
2nd commonest neurodegenerative disease of neurons in the nigrostrialdopamine system
Clinical Features of Parkinson's Disease
Cardinal Features Other Motor Features Nonmotor Features
Bradykinesia
Rest tremor
Rigidity
Gait disturbance/postural
instability
Micrographia
Masked facies
(hypomimia)equalize
Reduced eye blink
Soft voice (hypophonia)
Dysphagia
Freezing
Anosmia
Sensory disturbances
(e.g., pain)
Mood disorders (e.g.,
depression)
Sleep disturbances
Autonomic disturbances
Orthostatic hypotension
Gastrointestinal
disturbances
Genitourinal disturbances
Sexual dysfunction
Cognitive
impairment/Dementia
1- Static tremors
Rhythmic occuring at a rate of 4-8 / second
May start in one hand and spread to other
parts of the body
Characteristically pill-rolling movements
between the thumb and the forefinger are
seen
Tremors increase with emotional, anxiety and
fatigue and disappear during sleep and during
active voluntary movements
2- Rigidity of the musclesMore proximal than distalFlexors are affected more than extensorOn clinical examination the resistance may be
continuous throughout the act to the samedegree (lead pipe rigidity) or interrupted bythe tremors (cog wheel rigidity)
Stiffness of the limbs develops causingdifficulty in starting movements and walking(slow, shuffling gait)
3- Akinesia: Loss of emotional and associative movements resulting in:
Immobile face with infrequent blinking (mask face)
Monotonous speech
Loss of swinging of the arms during walking
Pathologically, the hallmark features of PD are degeneration of dopaminergicneurons in the substantia nigra pars compacta (SNc), reduced striatal dopamine,and intracytoplasmic proteinaceous inclusions known as Lewy bodies.
neuronal degeneration with inclusion body formation can also affect cholinergicneurons of the nucleus basalis of Meynert (NBM), norepinephrine neurons of thelocus coeruleus (LC), serotonin neurons in the raphe nuclei of the brainstem, andneurons of the olfactory system, cerebral hemispheres, spinal cord, andperipheral autonomic nervous system.
Indeed, there is evidence that pathology begins in the peripheral autonomicnervous system, olfactory system, and dorsal motor nucleus of the vagus nerve inthe lower brainstem, and then spreads in a sequential manner to affect the upperbrainstem and cerebral hemispheres. These studies suggest that dopamineneurons are affected in midstage disease.
Several studies suggest that symptoms reflecting nondopaminergic degenerationsuch as constipation, anosmia, rapid eye movement (REM) behavior sleepdisorder, and cardiac denervation precede the onset of the classic motor featuresof the illness.
Differential Diagnosis of Parkinsonism
Parkinson's Disease
Genetic
Sporadic
Dementia with Lewy
bodies
Atypical
Parkinsonisms
Multiple-system
atrophy
Cerebellar type
(MSA-c)
Parkinson type
(MSA-p)
Progressive
supranuclear palsy
Corticobasal
ganglionic
degeneration
Frontotemporal
dementia
Secondary
Parkinsonism
Drug-induced
Tumor
Infection
Vascular
Normal-pressure
hydrocephalus
Trauma
Liver failure
Toxins (e.g.,
carbon monoxide,
manganese,
MPTP, cyanide,
hexane, methanol,
carbon disulfide)
Other Neurodegenerative
Disorders
Wilson's disease
Huntington's disease
Neurodegeneration with
brain iron accumulation
SCA 3 (spinocerebellar
ataxia)
Fragile X–associated
ataxia-tremor-
parkinsonism
Prion disease
Dystonia-parkinsonism
(DYT3)
Alzheimer's disease with
parkinsonism
Modern immunocytochemical techniques and genetic findings suggest that Parkinson-plus syndromes can be broadly grouped into 2 types: synucleinopathies and tauopathies. Clinically, however, 5 separate Parkinson-plus syndromes have been identified, as follows:
1. Multiple system atrophy2. Progressive supranuclear palsy3. Parkinsonism-dementia-amyotrophic lateral sclerosis complex4. Corticobasal ganglionic degeneration5. Diffuse Lewy body diseaseParkinson-plus syndromes respond poorly to the standard
treatments for Parkinson disease (PD).
In addition to lack of response to levodopa/carbidopa(Sinemet) or dopamine agonists in the early stages of the disease, other clinical clues suggestive of Parkinson-plus syndromes include the following:
History and Examination Features Suggesting Diagnoses Other Than Parkinson's
Disease
Symptoms/Signs Alternative Diagnosis to Consider
History
Falls as the first symptom PSP
Exposure to neuroleptics Drug-induced parkinsonism
Onset prior to age 40 If PD, think genetic causes
Associated unexplained liver disease Wilson's disease
Early hallucinations Lewy body dementia
Sudden onset of parkinsonian symptoms Vascular parkinsonism
Physical Exam
Dementia as first symptom Dementia with Lewy bodies
Prominent orthostasis MSA-p
Early dysarthria MSA-c
Lack of tremor Various Parkinson's-plus syndromes
High frequency (8–10 Hz) symmetric tremor Essential tremor
Diagnosis of PD
clinical examination
No disease-specific biological marker
available
Positron Emission Tomography (PET)
or Single-photon Emission Computed
Tomography (SPECT) with
dopaminergic radioligands
Exclusion of several causes of
secondary Parkinsonism
(A) Dopamine Carbidopa/l-dopa Dopamine agonists: Apomorphine(off phenomenon), s/c, i.v.
CabergolineRopinirole, Pramipexole
COMT inhibitors: Entacapone MAO Inhibitors: e.g. Selegiline (B-type) Inhibitors of dopamine re-uptake: Amantadine
(2) Acetylcholine Anticholinergic
Antihistaminics
Drugs commonly used in the treatment of Parkinson disease
MEDICATION
STARTING
DOSE
TARGET
DOSE MAIN BENEFIT SIDE EFFECTS
Carbidopa-L-dopa
(Sinemet)
25/100 tid
empty
stomach
Up to 50/250
q 3 h
Reduction of tremor and
bradykinesia; less effect on
postural difficulties
Nausea, dyskinesias, orthostatic
hypotension, hallucinations,
confusion, arrhythmia
Controlled release
carbidopa-L-dopa
25/100 tid Up to 50/200
q 4 h
Dopamine agonists
Ropinirole(D3) 0.125 mg
tid
0.5 to 1.5
mg/day
Moderate effects on all
aspects; reduced motor
fluctuations of L-dopa,
neuroprotective, neurotrophic
Orthostatic hypotension,
excessive and abrupt
sleepiness, confusion,
hallucinations, impulse control
disorders
Pramipexole(D2) 0.25 mg tid 8 to 24
mg/day
Glutamate agonist
Amantadine
(Symmetrel)
100
mg/day
100 mg bid-tidSmoothing of motor
fluctuations
Leg swelling, congestive heart
failure, prostatic outlet
obstruction, confusion,
hallucinations, insomnia
Anticholinergics
Benztropine
(Cogentin)
0.5 mg per
day
Up to 4 mg
per day
Tremor reduction, less effect
on other features, drug
induced parkinsonism
Atropinic effects: dry mouth,
urinary outlet obstruction,
confusion and psychosisTrihexyphenidyl
(Artane)
0.5 mg bid Up to 2 mg tid
MAO-B inhibitor
selegiline, 5mg/day bd Neuroprotection, adjuntive
therapy
Insomnia
Rasagiline 1mg/day
COMT inhibitors
Entacapone 200 mg with L-dopa Urine discoloration, diarrhea,
increased dyskinesias
Stereotactic neurosurgery: pallidotomy, thalamotomy ,sub thalamotomy
Indications1.idiopathic parkinsons2.levodopa unhelpful3.intractable PD4.drug dyskinesias
Deep brain stimulation: dyskinesia Tissue transplantation: Experimental transplantation of fetal
or autologous dopamine-containing adrenal medulla or stemcell research has produced no promising results in PD to date.
Physiotherapy and physical aids Neuropsychiatric aspects: Cognitive impairment and
depression are common as PD progresses. SSRIs are thedrugs of choice for depression.
Sudden, brief, rapid, jerky, purposeless, non-
repetitive, involuntary movement
Most characteristically in distal parts of upper
extremity but may also involved proximal part,
lower extremity, trunk, face & tongue
PATHOLOGY
Damage to caudate nucleus
Disease characterized by chorea: Inherited disorder: Huntington disease, wilson
disease, benign hereditry chorea,neuroacanthocytosis
Infectious causes: Rheumatic chorea(sydenham chorea), HIV disease
Structural lesion of the basal ganglia- infarct,neoplasm, trauma
Chorea of systemic disease: SLE, thyrotoxicosis, polycythemia vera, hyperosmolar non-ketotic hyperglycemia
Pregnancy (chorea gravidarum)Drugs: Neuroleptics, OCP, excessive dose of
levodopa or dopamine agonist, phenytoincocaine
Hypotonia Pronator sign Milkmaid’s grip Spooning sign Pendular knee jerk “hung up reflex” Lizard tongueIncreased by excitement, diminished by sleepSydenham chorea (Saint vitus dance) more common in
female and childhood (5-15yrs), associated with prior exposer to group a streptococcal infection, late manifestation
Huntington's disease progressive fatal autosomaldominant disorder characterized by motor, behavioral & cognitive dysfunction, in early stages chorea is focal or segmental but it progress over time to involve multiple body region
Etiology HD is caused by an increase in the
number of polyglutamine (CAG)repeats (>40) in the coding sequenceof the huntingtin gene located on theshort arm of chromosome 4. The largerthe number of repeats, the earlier thedisease is manifest.
Treatment multidisciplinary approach Dopamine-blocking agents may control
the chorea. Tetrabenazine depression and anxiety can be greater
problems, and patients should betreated with appropriate antidepressantand antianxiety drugs and monitored formania and suicidal ideations.
Psychosis can be treated with atypicalneuroleptics such as clozapine,quetiapine, and risperidone
There is no adequate treatment for thecognitive or motor decline
Slow, distal, purposeless, writhing involuntarymovement
They are more sustained and larger in amplitudethan those in chorea
The mainly involved the extremities (distalportion, fingers & hands) face, neck & trunk
Movement are characterized by any combinationflexion, extension, abduction, pronation, &supination often alternating and in varyingdegree
Predominant pathologic changes are in theputamen
Causes: cerebral palsy, perinatal injury to basal ganglia, wilson disease
Choreoathetosis: the movement live between chorea & athetosis in rate and rhythmicity eg: cerebral palsy ( Neonatal jaundice)
Pseudoathetosis: (sensory athetosis) undulating & writhing movement of extremities due to loss of position sense as a result of parietal lobe lesion, tabesdorsalis, peripheral nerve disease
A wild, flinging, large amplitude movements on one side of the body
Proximal upper limb muscles predominantly affected
Ballastic movement of hemiballismus resemble that of chorea but are more pronounced, rapid & forceful
Movement ceaseless during the walking state and disappear only with the deep sleep
Usually self limiting and tends to resolve spontaneously after weeks to months
Due to infarction or hemorrhage in the regions of contralateral subthalamic nucleus, results in disinhibition of the motor thalamus and cortex resulting in contralateralhyperkinetic movement.
Treatment: Dopa blocking agentPallidotomy can be done.
Sustained or repetitive involuntary muscle contraction leading to twisting
movements and abnormal posture
Can involve individual muscle or multiple muscle groups.
Often affect the extremities neck, trunk, eyelids, face & vocal cords
Dystonic movements are patterned tending to recur in same location
When duration is very brief less than one second- dystonic spasm, when
for several seconds, dystonic movement & when prolonged minutes to
hours- dystonic posture
Pathophysiology of Dystonia
not known.
co-contracting synchronous bursts of agonist and antagonist muscle groups
due to loss of inhibition at multiple levels of the nervous system as well as
increased cortical excitability and reorganization.
Attention has focused on the basal ganglia as the site of origin of at least
some types of dystonia as there are alterations in blood flow and metabolism
in basal ganglia structures. Further, ablation or stimulation of the globus
pallidus can both induce and ameliorate dystonia.
Dystonia can be generalized or focal: primary orsecondary
Generalized dystonia is mainly primarydystonia involving larger portion of body oftenproducing distorted posture of limbs & trunk(Torsion dystonia)
Idiopathic torsion dystonia (dystonia musculormdeformance) is predominantly childhood onsetform of dystonia with autosomal dominantpattern of inheritance
May starts distally usually in the foot in theplanter flexation & inversion & speed to oppositeside, upper extremity trunk & face
There is peculiar axial involvement of spine(twisting)
Dopa responsive dystonia ( Segawa variant) dominantly inherited form of dystonia in early childhood 1-12yrs typically present with foot dystonia resulting in gait disturbance and there is excellent response to small doses of levodopa.
Diurnal variation, worsen with day progresses
Focal dystonia is a most common, 4th to 6th
decade and more common in female:• Blephero spasm• Oromandibular dystonia• Spasmodic dysphonia• Cervical dystonia• Limb dystonia (writer’s cramp)
Secondary dystonia:Due to drugs: Neuroleptics,
(Phenothiazine, Butyrophenone), chroniclevodopa treatment in parkinsons disease
Discrete lesion in the stratum, palladum,thalamus, cortex & brain stem
Dystonia plus syndrome:May occur in the neurodegenerative
condition (Huntington disease, Wilsondisease, parkinson disease, corticobasaldegeneration & progressive supranuclearpalsy)
symptomatic Levodopa should be tried in all cases of childhood-onset dystonia to
rule out DRD. High-dose anticholinergics (e.g., trihexyphenidyl 20–120 mg/d) may
be beneficial in children, but adults can rarely tolerate high doses because of cognitive impairment with hallucinations.
Oral baclofen (20–120 mg), Tetrabenazine (the usual starting dose is 12.5 mg/d and the average treating dose is 25–75 mg/d) may be helpful in some patients, but use may be limited by sedation and the development of parkinsonism.
Botulinum toxin has become the preferred treatment for patients with focal dystonia, particularly where involvement is limited to small muscle groups such as in blepharospasm, torticollis, and spasmodic dysphonia.
Surgical therapy is an alternative for patients with severe dystoniawho are not responsive to other treatments. Peripheral procedures such as rhizotomy and myotomy were used in the past to treat cervical dystonia, but are now rarely employed. DBS of the pallidumcan provide dramatic benefits for patients with primary DYT1 dystonia
Supportive treatments such as physical therapy and education are important and should be a part of the treatment regimen.
Sudden, brief (<100ms) shock like, jerkyinvoluntary movement consisting of single orrepetitive muscle discharges
Myoclonus is seen principally in the muscles ofextremities and trunk but the involvement is oftenmultifocal, diffuse or wide spread
Can often spontaneously, association withvoluntary movement (action myoclonus) or inresponse to external stimulus (reflex or startlemyoclonus)
Myoclonic jerks defer from tics in that theyinterfere with normal movement and notsuppressible
Symptomatic causes of myoclonus: Metabolic endogenous- Hypoxia, uraemia,
hepatic failure, hypoglycemia, hyponatraemia,non-ketotic hyperglycemia
Degenerative: Alzheimer’s disease, Huntingtondisease, multisystem atrophy, corticobasaldegeneration
Infectious: Creutzfeldt –Jakob disease, EBV etc Autoimmune: Multiple sclerosis Neoplastic: Neuroblastoma, paraneoplastic
disorders (ovarian, lung & breast) Frequently associated with epilepsy, electric
shock, heat stroke Drugs: Amantadine, lithium, metoclopramide,
levodopa & dopamine agonist, cocaine,strychnine
Opsoclonus- Myoclonus (Kinsbournesyndrome)- Dancing eye & dancing feet
Due to the post infectious encephalopathy or as aparaneoplastic syndrome due to neuroblastoma
Palatal myoclonus- involuntary rhythmic movementof soft palate and pharynx the movements aregenerally not influenced by drugs or sleep palatalmyoclonus occur with lesions involving theconnections between the inferior olivary, dentate &red nuclei
Astrexis: particularly in hepatic encephalopathy,negative myoclonus inability to sustained normalmuscle tone presenting with slow & irregularflapping motion
Acute- Dystonia is most common acute drugreaction can develop within minutes of exposuretypically generalized in children and focal in adults
Treatment: parenteral administration ofanticholinergics (benztropine or diphenhydramine)or benzodiazepines (lorazepam or diazepam).
Subacute- Akathisia is commonest reaction itconsist of motor restlessness within in need to moveand that to elevated by movement.
Treatment: Removing the offending agent.If notpossible, give benzodiazepines, anticholinergics,blockers, or dopamine agonists for symptomaticimprovement.
Chronic- Tardive syndrome after months to years after initiation of treatment A typically comprises choreiform movement involving the mouth lip, tongue, and in severe cases trunk, limbs and respiratory muscles can be affected Is more common in elderly women & with underlying organic cerebral dysfunction (Schrizophrenia)
Brief, repeated, sterotyped muscle contraction that often suppressible
Quick, irregular, seemingly purposeful act but relatively involuntary
Patient have some degree of awareness of movement and in response to urge of some compelling inner forces
Exaggerated by emotional strain and tension and stop during sleep
May involved any portion of body
Eg: Repetitive blinking, facial contortions, shoulder shrugging, also involved vocal tract producing throat clearing
Gilles de la Tourette Syndrome characterized by multiple motor tics and vocalizations
Motor tics can be simple/ complex & vocal tics can be simple (grunting) or complex (echolalia)
Tourette syndrome is a disease of early childhood in the first decade and mainly in Boys an associated with some regressive behaviour
Contrary to dopamine, it can pass into the brainwhere it is decarboxylated into dopamine
Levodopa is combined with a peripheral L-AAdecarboxylase inhibitor e.g. carbidopa orbenserazid to delivery of l-dopa into the brain peripheral adverse effects of dopamine
Carbidopa if peripheral adverse effects areprominent
It has dramatic initial response, decreases withtime (wear off) due to the progressive loss ofneurons
Combined with carbidopa is the most
potent oral therapy for Parkinson’s disease
Symptoms of Parkinson’s disease but
does not stop the progression
(deterioration) of the disease i.e.
Symptomatic treatment
From the third year its efficacy declines
Peripheral:• GIT: Nausea & Vomiting• CVS: Orthostatic hypotension, Dysrhythmias• Blood dyscrasias & Positive reaction to Coombs
test• Mydriasis and Brownish discoloration of urine &
saliva CNS Effects:
• Visual & Auditory hallucinations & vivid dreams• Dyskinesias: opposite of Parkinsonian symptoms• Mood changes, depression & Anxiety
Long-term levodopa Complications:• Wearing off (fluctuations), Dyskinesias
Ergot alkaloid derivatives:
Bromocriptine & Pergolide
Non-ergot alkaloid derivatives:
Pramipexole & Ropinirole
Have longer duration less fluctuationHave less tendency to induce dyskinesia Ineffective in patients not responding to
leveodopaCan be used in early cases to delay use
of levodopa (in levodopa-naïve patients)& in advanced cases to augment
levodopa and to decrease fluctuations to its response
Pergolide is more potent than Bromocriptine Their side effects limit their use and slow rapid
build up of doses (over 2-3 Months)
Side effects include levodopa side effects in addition to spasmogenicity & fibrosis (of serous membranes)
Pramipexole & Ropinirole
Pramipexole: is cleared by renal
excretion
Ropinirole: is cleared by metabolism
Side effects as levodopa with less
dyskinesia and fluctuation and
No spasmogenicity and
fibrosis
Antiviral (influenza) drug
The mode of action is unknown • # NMDA glutamate receptors (the primary action)• # Muscarinic receptors• Increases release of dopamine
It has little effect on tremors &
Tolerance develops rapidly
Augment the effect of dopamine Weak and play an adjuvant role They are the same in efficacy but with some inter-
individual variation in responseSide effects: Mood changes Xerostomia, blurred vision, constipation, urinary
retention Hallucination, confusion
C/I: in glaucoma, SPH, Pyloric stenosis
Parkinson-plus syndromes respond poorly to the standard treatments for Parkinson disease (PD).
In addition to lack of response to levodopa/carbidopa (Sinemet) or dopamine agonists in the early stages of the disease, other clinical clues suggestive of Parkinson-plus syndromes include the following: Early onset of dementia
Early onset of postural instability
Early onset of hallucinations or psychosis with low doses oflevodopa/carbidopa or dopamine agonists
Ocular signs, such as impaired vertical gaze, blinking on saccade,square-wave jerks, nystagmus, blepharospasm, and apraxia of eyelidopening or closure
Pyramidal tract signs not explained by previous stroke or spinal cordlesions
Autonomic symptoms such as postural hypotension and incontinenceearly in the course of the disease
Prominent motor apraxia
Alien-limb phenomenon
Marked symmetry of signs in early stages of the disease
Truncal symptoms more prominent than appendicular symptoms
Absence of structural etiology such as a normal-pressure hydrocephalus(NPH)
Tremor is rhythmic, involuntary, purposeless oscillatory movement of body part due to intermittent muscle contraction
Types: i. Rest ii. Postural iii. Intention Rest Tremor: is maximum at rest & becomes less
prominent with activity eg: parkinson disease, Postural Tremor: is maximum while limb posture
is actively maintained against gravity (arm outstretched) eg: Essential tremor, enhanced physiologic tremor,
Intention Tremor: Most prominent during voluntary movement toward a target eg: cerebellar disease
Etiology: Parkinsonism
Essential tremor
Physiologic tremor
Alcohol
Anxiety
Thyrotoxicosis
Cerebellar disease
Wilson disease
Red nuclear tremor
Drugs (-2agonist, sympathomimetics,methylxanthine, amphetamine, anticonvulsant,
Poison (Mercury, MPTP)
Essential tremor: Most common involuntary movement disorder
High frequency, coarse mainly distal upper extremity & later become bilateral symmetrical
Maximum when trying to maintain a posture Autosomal dominant pattern of inheritance Characteristically improve with alcohol & -
blocker
Parkinsonism is a slow (4-6 Hz) coarse, rest tremor typically appears unilaterally, pill rolling tremor
Physiologic Tremor: In normal individual 8-12Hz, mainly young adults
Cerebellar tremor: intention tremor,coarse & irregular
Thyrotoxic tremor: fine & rapid but maybe complicated by choreiform involuntarymovement
Red nuclear tremor: the severe, largeamplitude, slow 2-5 Hz, involve bothproximal & distal muscle present at restbut made worse with action
Fine rapid, flickering or vermicular twitching
movements due to contraction of a bundle or
fasciculus of muscle fibers
Fasciculations are much more gross than
fibrillation and can be seen through intact skin
and this continue during sleep
Exaggerated by fatigue, cold, cholinergic drugs,
caffine
Characteristic feature of motor neuron disease,
anterior horns cell disease
Involuntary, spontaneous, localized, transient or persistent quivering movement that affect a few muscle bundles with in a single muscle
Coarse, slower, worm like, usually more prolonged and involved in wide local area than fasciculation
Not affected by motion or position and persist during sleep
Most commonly present in orbicularis oculi Generalized myokymia (Isaac’s syndrome)
generalized muscle stiffness and persistent contraction due to underlying continuous muscle fiber activity
Slow 2-3Hz rhythmic alternating movement
resemble tremor
Wide spread involvement, may involved multiple
body parts
Absent during sleep
May be intermittent or continuous, synchronous
or asynchronous
Eg: CNS whipple’ disease